Suppression of MALAT1 can alleviate myocardial injury and inflammation in HF patients, while inhibiting miR-532–3p may reduce MALAT1’s protective effect on H9C2 cardiomyocyte injury. This evidence concerns the gene MALAT1 and hydrops fetalis.